RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease Jul 13, 2017 Life Science
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman Jul 12, 2017 Life Science
Resverlogix and Hepalink Start Taiwan/China Trial of CVD/Diabetes Treatment Jul 11, 2017 Life Science
FosunPharma to Spend $73.5 Million on Global Technology Incubator Jul 11, 2017 Life Science, Technology
Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial Jul 11, 2017 Life Science, Technology
BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in China in Patients with Urothelial Cancer Jul 6, 2017 Life Science
DelMar Pharmaceuticals Joins National Brain Tumor Society’s Research Roundtable Jun 30, 2017 Life Science
Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone Jun 29, 2017 Life Science
